Skip to Main Content

As more companies gear up to fight the spread of the novel coronavirus, a growing number of government officials, lawmakers, academics, and advocacy groups are seeking to ensure widespread access to medical products for combating Covid-19.

Over the past two days, more than 30 members of the European Parliament and dozens of advocacy groups separately urged the European Commission to avoid granting monopolies that might allow manufacturers to eventually charge prices for medicines, vaccines, or diagnostics that would be out of reach for poorer populations around the world.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • I fully understand the Importance of Clinical Trials. Except in this moment of Potential life saving treatment. Being delayed at the cost of many Human life’s I believe that anyone currently surviving on a resperator is involved in a clinical trial as well as there loved ones. What we need is Hope!

  • But US drug manufacturers spend millions each year buying politicians on both sides of the aisle. We can’t allow peoples’ lives to matter more than money money money.

Comments are closed.